发明名称 HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE (MMP) INHIBITORS
摘要 <p>Compounds of formula ( or pharmaceutically or veterinarily acceptable salts thereof, or pharmaceutically or veterinarily acceptable solvates of either entity, wherein the broken line represents an optional bond; A is C or CH; B is CH2, O or absent; R1 & R2 are each independently selected from hydrogen,C1 to C6 alkyl optionally substituted with C1 to C4 alkoxy or phenyl, and C1 to C6 alkenyl; or together with the carbon atom to which they are attached, form a C3 to C6 cycloalkyl group which optionally incorporates a heteroatom linkage selected from O, SO, SO2 and NR6 or which is optionally benzo-fused; R3 is hydrogen, halo, R7 or OR7; R4 is hydrogen, C1 to C4 alkyl, C1 to C4 alkoxy, trifluoromethyl or halo; R6 is hydrogen or C1 to C4 alkyl; R7 is an optionally substituted monocyclic or bicyclic ring system, m is 1 or 2; and n is 0 ,1 or 2; with the proviso that B is not O when A is C; are MMP inhibitors useful in the treatment of, inter alia, tissue ulceration, wound repair and skin diseases. 23 claims</p>
申请公布号 BG104506(A) 申请公布日期 2001.01.31
申请号 BG20000104506D 申请日期 2000.06.05
申请人 PFIZER INC. 发明人 DACK, KEVIN N.;WHITLOCK, GAVIN A.
分类号 C07D205/04;A61K31/397;A61K31/44;A61K31/4427;A61K31/443;A61K31/445;A61K31/451;A61K31/4525;A61K31/453;A61K31/454;A61K31/4545;A61K31/4709;A61P9/00;A61P9/04;A61P9/10;A61P17/00;A61P17/02;A61P19/02;A61P29/00;A61P35/04;A61P43/00;C07D211/16;C07D211/22;C07D211/70;C07D211/96;C07D401/10;C07D405/10;C07D405/12;(IPC1-7):C07D211/16 主分类号 C07D205/04
代理机构 代理人
主权项
地址